Adamas Pharma LLC manufactures pharmaceutical products. The company is headquartered in Emeryville, CA.

Liomont is a pharmaceutical company that researches, develops and manufactures medicines for medication, prescription and OTC markets.

Tianjin Minxiang Pharmaceutical Co., Ltd., established on 2008-01-24, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export;Sales of pharmaceutical precursor chemicals;Hazardous Chemical Production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Import and export agency;total mass4.5Road freight transport of ordinary freight vehicles of 1 ton or less(Except network freight and dangerous goods);Non-residential real estate leases.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shandong Holly Pharmaceutical Co., Ltd. is a private company headquartered in Binzhou City, China. The firm manufactures pharmaceutical products.

Guangdong Renkangda Material Technology Co., Ltd., established on 2019-10-25, Business scope includes production,research and development,Sales:Fine Chemicals and Intermediates,Petrochemical Additives,Adamantane,Bromoadamantane,Amantadine Hydrochloride,flocculant,isotridecyl alcohol,Tributene,Isododecene,mixed alcohol,Industrial Sodium Sulfate,Isogenic Tridecyl Ether(The above does not contain dangerous chemicals and flammable and explosive materials).Goods and technology import and export business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hainan General Sanyang Pharmaceutical Co. Ltd. is a company headquartered in Haikou, China and ultimately controlled by the Government of China. The firm manufactures and distributes pharmaceuticals.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland.

Degussa AG is the world's third largest producer of precious metals. The company operates three divisions; precious metals and banking, which is involved in precious metals trading, production of precious metals and the manufacture of precious metal compounds and products in addition to operating its own bank, 'Degussa Bank', which is a universal bank providing traditional banking services. Chemical products is the second division and is involved in manufacturing fine and special chemicals, rubbers, pigments and chemical catalysts. The third and final division, health and nutrition is involved in manufacturing pharmaceuticals, dental chemicals and fodder additives. The company has subsidiaries in Germany, other European countries, USA, Brazil, Singapore, Japan and South Korea.

MediWound is a biotechnology niche-specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burns and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative burn wound eschar removal agent, NexoBrid. NexoBrid successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.

Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. They focus on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505b2 approach). The company develops products in two therapeutic areas with great unmet needs - Parkinson's disease (PD) and Cancer.

Qingdao Hailan Pharmaceutical Co., Ltd., established on 2013-05-20, Business scope includes general business items:medical products,Research and development of pharmaceutical preparations,Technical testing,technology transfer;Research and development of biotechnology and products,technical consulting,Technical Services. (The above scope needs to be licensed to operate,Operate with a license).

Beijing Sannuo Jiayi Biotechnology Co., Ltd., established on 2002-05-29, Business scope includes medical technology development,Technology Promotion,technology transfer,technical consulting,Technical Services,Technical Training.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

L'Air Liquide SA engages in gas supply for large industry and health businesses. It operates through the following segments: Gas & Services, Engineering & Construction, and Global Markets & Technologies. The Gas & Services segment activities are organized by geographical areas, which determine sales policies and development projects. The Engineering & Construction segment designs, develops and builds industrial gas production plants. The Global Markets & Technologies segment focuses on new markets which require a global approach, drawing on science, technologies, development models, and usages related to digital transformation. The company was founded by Georges Claude and Paul Delorme on November 8, 1902 and is headquartered in Paris, France.

Part of Catalent, Inc., Columbia Laboratories (Bermuda) Ltd. is a Bermudian company located in Hamilton. The firm manufactures pharmaceutical products.

Tianjin Minxiang Biomedical Co., Ltd. (stock code: 834738) was founded in 2005 with registered capital of ¥67.3 million. It is a high-tech enterprise that engages in researching, developing and manufacturing biological medicines, chemical raw medicines, preparations, intermediates, and new drugs. The company has many R&D staffs in chemical synthesis, development of chemical technology, detection and quality analysis. Moreover, the company has hired some experts to offering guidance in the fields of information collection, R&D, and scientific research cooperation.

Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.